Island Pharmaceuticals Zukünftiges Wachstum
Future Kriterienprüfungen 0/6
Island Pharmaceuticals is forecast to grow earnings at 4.1% per annum. EPS is expected to grow by 40.9% per annum.
Wichtige Informationen
4.1%
Wachstumsrate der Gewinne
40.9%
EPS-Wachstumsrate
Pharmaceuticals Gewinnwachstum | 54.6% |
Wachstumsrate der Einnahmen | n/a |
Zukünftige Eigenkapitalrendite | n/a |
Analystenabdeckung | Low |
Zuletzt aktualisiert | 19 Aug 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Keine Aktualisierungen
Recent updates
Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
6/30/2024 | 1 | -3 | -3 | -3 | N/A |
3/31/2024 | 1 | -3 | -3 | -3 | N/A |
12/31/2023 | 1 | -2 | -3 | -3 | N/A |
9/30/2023 | 0 | -3 | -3 | -3 | N/A |
6/30/2023 | N/A | -3 | -3 | -3 | N/A |
3/31/2023 | N/A | -3 | -3 | -3 | N/A |
12/31/2022 | N/A | -3 | -2 | -2 | N/A |
9/30/2022 | N/A | -3 | -2 | -2 | N/A |
6/30/2022 | N/A | -3 | -2 | -2 | N/A |
3/31/2022 | N/A | -3 | -2 | -2 | N/A |
12/31/2021 | N/A | -3 | -2 | -2 | N/A |
9/30/2021 | N/A | -3 | -1 | -1 | N/A |
6/30/2021 | N/A | -2 | -1 | -1 | N/A |
6/30/2020 | N/A | 0 | N/A | N/A | N/A |
12/31/2019 | N/A | -1 | -1 | -1 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: ILA is forecast to remain unprofitable over the next 3 years.
Ertrag vs. Markt: ILA is forecast to remain unprofitable over the next 3 years.
Hohe Wachstumserträge: ILA is forecast to remain unprofitable over the next 3 years.
Einnahmen vs. Markt: Insufficient data to determine if ILA's revenue is forecast to grow faster than the Australian market.
Hohe Wachstumseinnahmen: Insufficient data to determine if ILA's revenue is forecast to grow faster than 20% per year.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Insufficient data to determine if ILA's Return on Equity is forecast to be high in 3 years time